24 min

Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer The Uromigos

    • Medicine

Nizar Tannir describes this randomised phase 3 study presented at ESMO. 

  • The Uromigos

Nizar Tannir describes this randomised phase 3 study presented at ESMO. 

24 min

  • The Uromigos